- Home
- GMED vs SNN Comparison
GMED vs SNN Comparison
Compare GMED & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- SNN
- Stock Information
- Founded
- GMED 2003
- SNN 1856
- Country
- GMED United States
- SNN United Kingdom
- Employees
- GMED N/A
- SNN N/A
- Industry
- GMED Medical/Dental Instruments
- SNN Industrial Specialties
- Sector
- GMED Health Care
- SNN Health Care
- Exchange
- GMED Nasdaq
- SNN Nasdaq
- Market Cap
- GMED 11.4B
- SNN 11.1B
- IPO Year
- GMED 2012
- SNN 1999
- Fundamental
- Price
- GMED $80.27
- SNN $26.13
- Analyst Decision
- GMED Buy
- SNN Strong Buy
- Analyst Count
- GMED 12
- SNN 1
- Target Price
- GMED $96.91
- SNN N/A
- AVG Volume (30 Days)
- GMED 1.3M
- SNN 567.3K
- Earning Date
- GMED 02-20-2025
- SNN 02-25-2025
- Dividend Yield
- GMED N/A
- SNN 2.87%
- EPS Growth
- GMED N/A
- SNN 39.77
- EPS
- GMED 0.75
- SNN 0.35
- Revenue
- GMED $2,519,355,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- GMED $62.96
- SNN $6.16
- Revenue Next Year
- GMED $6.61
- SNN $4.65
- P/E Ratio
- GMED $107.04
- SNN $37.35
- Revenue Growth
- GMED 60.62
- SNN 5.48
- 52 Week Low
- GMED $49.33
- SNN $23.65
- 52 Week High
- GMED $94.93
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- GMED 25.39
- SNN 59.89
- Support Level
- GMED $83.33
- SNN $25.54
- Resistance Level
- GMED $85.50
- SNN $26.09
- Average True Range (ATR)
- GMED 2.29
- SNN 0.33
- MACD
- GMED -1.03
- SNN 0.06
- Stochastic Oscillator
- GMED 5.34
- SNN 95.62
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.